Breast IHC AI

Indica Labs' HER2 low and ultralow UI

Low and Ultralow HER2 Expression in Breast Cancer is Now Detectable by Indica Labs’ Breast IHC AI

Breast IHC AI, HALO AP, HALO Clinical AI, News, Press Releases / , ,

Albuquerque, NM, April 30, 2025 – Indica Labs, the leading provider of AI-powered digital pathology solutions, announces today an update to their Breast IHC AI suite, an image analysis tool used for the quantification of HER2, ER, PR, and Ki67 within AI-identified, tumor regions, of breast cancer tissue specimens. The HER2 algorithm will now include functionality for the detection of low and ultralow HER2 expression in breast cancer.

Low and Ultralow HER2 Expression in Breast Cancer is Now Detectable by Indica Labs’ Breast IHC AI Read More »

The Institute of Molecular Pathology and Immunology of the University of Porto (IPATIMUP) Selects Indica Labs’ HALO AP® to Deliver AI-enabled Diagnostics

Breast IHC AI, HALO, HALO AI, HALO AP, HALO Clinical AI, Lung Macrodissect AI, News, Press Releases / , , , , ,

Albuquerque, NM, October 30, 2024 – The Institute of Molecular Pathology and Immunology of the University of Porto (IPATIMUP), among the leading institutes for clinical digital pathology and research in the European Union, has partnered with Indica Labs to implement digital primary diagnostics with integrated AI-powered image analysis.

The Institute of Molecular Pathology and Immunology of the University of Porto (IPATIMUP) Selects Indica Labs’ HALO AP® to Deliver AI-enabled Diagnostics Read More »

Free Demo
Free Demo
Scroll to Top